Fungal diseases are responsible for the deaths of over 1.5 million people worldwide 14 annually. Antifungal peptides represent a useful source of antifungals with novel 15 mechanisms-of-action, and potentially provide new methods of overcoming resistance. Here 16 we investigate the mode-of-action of the small, rationally designed synthetic antifungal 17 peptide PAF26 using the model fungus Neurospora crassa. Here we show that the cell 18 killing activity of PAF26 is dependent on extracellular Ca 2+ and the presence of fully 19 functioning fungal Ca 2+ homeostatic/signalling machinery. In a screen of mutants with 20 deletions in Ca 2+ -signalling machinery, we identified three mutants more tolerant to PAF26. 21 The Ca 2+ ATPase NCA-2 was found to be involved in the initial interaction of PAF26 with the 22 cell envelope. The vacuolar Ca 2+ channel YVC-1 was shown to be essential for its 23 accumulation and concentration within the vacuolar system. The Ca 2+ channel CCH-1 was 24 found to be required to prevent the translocation of PAF26 across the plasma membrane. In 25 the wild type, Ca 2+ removal from the medium resulted in the peptide remaining trapped in 26 small vesicles as in the Δ yvc-1 mutant. It is therefore apparent that cell killing by PAF26 is 27 complex and unusually dependent on extracellular Ca 2+ and components of the Ca 2+ -28 regulatory machinery. 29
Introduction

45
Fungal infections today are among the most difficult diseases to manage in 46 humans (Kohler, Casadevall et al. 2014 ). Fungi collectively kill over 1.5 million people annually which is more than malaria and similar to the death toll from tuberculosis (Brown, al. 2013) . As a result of these studies, PAF26 has been proposed as a simple peptide model (Wada, Ohsumi et al. 1987 , Yang and Sachs 1989 , Bertl and Slayman 1990 162 Zasloff et al. 1991 , Antebi and Fink 1992 , Iida, Nakamura et al. 1994 , Lapinskas, Cunningham et al. 163 1995 , Levina, Lew et al. 1995 , Paidhungat and Garrett 1997 , Erdman, Lin et al. 1998 , Kanzaki 1999 164 Benito, Garciadeblas et al. 2000 , Locke, Bonilla et al. 2000 , Muller, Locke et al. 2001 , Palmer, Zhou 165 et al. 2001 , Courchesne 2002 , Courchesne and Ozturk 2002 , Denis and Cyert 2002 , Gupta, Ton et 166 al. 2003 , Kaiserer, Oberparleiter et al. 2003 , Muller, Mackin et al. 2003 , Zhou, Batiza et al. 2003 Zelter, Bencina et al. 2004 , Brand, Shanks et al. 2007 , Hallen and Trail 2008 168 2008 , Benito, Garciadeblás et al. 2009 , Bormann and Tudzynski 2009 169 2009 , Binder, Chu et al. 2010 , Bowman, Abreu et al. 2011 , Cavinder, Hamam et al. 2011 170 171 PAF26 is taken up by wild type macroconidia into vacuoles which 174 fuse and then lyse before releasing the peptide into the cytoplasm 175 In order to compare the dynamic pattern of peptide-cell interactions between the wild 176 type and the mutants, PAF26 labelled with the fluorophore TAMRA (TMR-PAF26) was 177 imaged. Fluorescent labelling has been previously employed to monitor, using confocal live-178 cell imaging, the dynamic localization of PAF26 or related peptides in a range of fungi. We 179 are confident that the dynamic pattern of TMR-PAF26 staining provides a faithful localization 180 of the unlabelled peptide in fungal cells and labelled/unlabelled peptides have similar IC 50 181 values (Muñoz, Marcos et al. 2012 , Muñoz, Gandía et al. 2013 , Muñoz, Harries et al. 2013 . 8 concentration of FITC-PAF26 (2.5 µM) exhibit a similar time-dependent staining pattern as 184 germlings treated with the same concentration of PAF26 (Muñoz, Marcos et al. 2012) . A 185 similar localization pattern of TMR-PAF26 interaction, internalization and distribution was 186 observed with ungerminated macroconidia to that of FITC-PAF26. The use of macroconidia 187 allowed a basic monitoring of cell volume, surface area and developmental state in relation 188 to possible variations in morphogenesis and staining patterns. In order to gain more insight into which stages of the PAF26 interaction, uptake and 211 distribution process the CCH-1, YVC-1 and NCA-2 proteins influence, the time-dependent 212 staining by TMR-PAF26 in each of the Δ cch-1, Δ yvc-1, and Δ nca-2 mutants were compared 213 with that in the wild type. As a baseline for the comparison, four staining patterns were 214 identified in the wild type macroconidia that could be readily quantified at 30 min intervals 215 
249
YVC-1 is required for transport of PAF26 from vesicles to vacuoles 250 When the ∆ yvc-1 mutant was treated with the labelled peptide ( Fig. 2B, 3B ), it rapidly 251 appeared at the cell envelope. Unlike with the wild type, the peptide was internalised into 252 small vesicles at a more-or-less linear rate with much remaining trapped at the cell surface. 253
Accumulation of the peptide in vacuoles was much slower and reached a maximum of 6% of 254 the cells with this localization pattern after 120 min. Virtually no cells were observed with 255 peptide exclusively in the cytoplasm at the three time points of measurement over the 120 256 min by which time only 5% of cells were internally permeabilised. After 120 min, 79% of the 257 ∆ yvc-1 cells had taken up TMR-PAF26 compared with 100% in the wild type. Thus, less 258 TMR-PAF26 was taken up by ∆ yvc-1 cells, most accumulated in small vesicles and few cells 259 had internal membrane permeabilisation after 120 min (5% compared with 57% in the wild 260 type). These results are consistent with YVC-1 being required for the transport of PAF26 261 from vesicles to vacuoles. 262 NCA-2 is required for the interaction of PAF26 and the cell envelope 263 When the ∆ nca-2 mutant was treated with TMR-PAF26 ( Fig. 2B and 3C) the cell 264 envelopes of the macroconidia were visibly less fluorescent than that of the wild type. Thus, 265 the affinity of TMR-PAF26 for the cell envelope of this mutant seemed to be reduced and its 266 staining was delayed compared with that of the wild type. The ∆ nca-2 macroconidia also 267 internalized TMR-PAF26 at a far reduced rate compared with the other mutants and the 268 peptide mostly became trapped within the small vesicles, resulting in virtually no TMR-269 PAF26 being taken up by vacuoles and a correspondingly extremely small percentage (~ 270 2%) of the cells having permeabilised internal membranes after 120 min ( Fig. 2B) . 271 The pattern of TMR-PAF26 internalization and intracellular transport within 274 macroconidia of the Δ cch-1 mutant appeared to be opposite to that in the wild type ( Fig. 3D ). 275
CCH-1 plays a key role in the energy-and Ca 2+ -dependent
After treatment for 30 min the peptide was primarily localized in the cytoplasm (in 67% of 276 cells) and to a much lesser extent in small vesicles (~ 18% of cells) and to a very low level in 277 large vacuoles (~ 5% of cells). Between 30 and 90 min, TMR-PAF26 was removed from the 278 cytoplasm and increased in amount in the small vesicles and large vacuoles. Between 90 279 and 120 min the large vacuoles containing TMR-PAF26 are fragmenting into smaller 280 vesicles. This was reflected by a dramatic increase in the number of stained small vesicles 281 ( Fig. 2B) . 282
The overall rate of internalisation of TMR-PAF26 by Δ cch-1 macroconidia was faster 283 than in the wild type because in the former it was initially taken up directly into the cytoplasm 284 whilst in the latter it first appeared intracellularly in small vesicles that are presumed to be 285 mostly endosomes. It seems unlikely that TMR-PAF26 is taken up by means of non-specific 286 permeabilization of the plasma membrane because this would likely have resulted in rapid 287 cell death. Furthermore, 30 min after the addition of TMR-PAF26 it was clear that the 288 vacuolar membrane had not become permeabilized because the peptide was excluded from 289 the vacuoles of cells in which the cytoplasm was fluorescent. 290
In order to clarify whether the passage of PAF26 across the plasma membrane into 291 the cytoplasm of the Δ cch-1 mutant was a result of passive translocation or active uptake, 292 macroconidia were pre-treated with the metabolic inhibitor NaN 3 (Muñoz, Marcos et al. 2012 ) 293 at a concentration of 5 µM for 15 min before the addition of TMR-PAF26 and subsequent 294 imaging and quantification of localization over 120 min (Figs. 2C and 3F). 295 In the presence of NaN 3 , over the whole 120 min period of incubation with TMR-296 PAF26, the peptide remained bound to the cell envelope and was not internalized by most of 297 the macroconidia. Clearly the metabolic inhibitor NaN 3 had almost completely abolished the 298 movement of TMR-PAF26 across the plasma membrane indicating that the uptake of the 299 peptide into the cells of the Δ cch-1 mutant is an ATP-dependent process. The results also 300 showed that the rate of internal membrane permeabilisation, whilst faster over the first 30 301 min, remained similar to that of the non-azide treated Δ cch-1 cells; after 120 min ~ 25% of 302 the cells were fluorescent throughout the cell. These results are consistent with the uptake of 303 TMR-PAF26 by this subpopulation of Δ cch-1 macroconidia being energy independent as a 304 result of a passive process. 305
These results are consistent with the normal endocytic internalization of PAF26 being 306 dependent on the Ca 2+ channel protein, CCH-1. As CCH-1 appears to initiate PAF26 reported to be immunolocalized to the plasma membrane (Locke et al., 2000) . Furthermore, 310
we had previously shown that removal of Ca 2+ from VM made macroconidia more resistant 311 to being killed by PAF26. To attempt to mimic the effect of cch-1 deletion in the wild type, 312
Ca 2+ was removed from the external medium by the addition of the Ca 2+ chelator BAPTA (5 313 mM) 30 min prior to the TMR-PAF26 treatment (Figs. 2C and 3E) . Rather than preventing 314 the entry of the peptide, the BAPTA treatment had the unexpected effect of trapping the 315 peptide in small vesicles. Over the 120 min period very little TMR-PAF26 had localized in 316 large vacuoles, in the cytoplasm and only ~ 11% of the macroconidia had fluorescence 317 throughout the cell. The phenotype of the measured for 50 sec, in the wild type this was calculated to be 0.05 ± 0.02 µM ( Fig. 4A) , 327 before the peptide was added at time 0. After treatment with a low final concentration of 328 PAF26 (1.25 µM), an immediate increase in [Ca 2+ ] cyt to 0.19 ± 0.01 µM was observed and 329 this was sustained throughout the measurement period (1,200 sec) and slightly increased 330 towards the end of this period ( Fig. 4B ). When the PAF26 added was at a final concentration 331 of 2.5 µM, which is close to its IC 50 value, the initial increase in [Ca 2+ ] cyt was slightly greater 332 (to 0.22 ± 0.03 µM) ( Fig. 4B ). Again, this was followed by a period of sustained [Ca 2+ ] cyt 333 increase, but there was also a more pronounced exponential increase in [Ca 2+ ] cyt which 334 began at ~ 900 sec after treatment. With the higher dose, there was also an increase in the 335 standard deviations of the measurements with time. This is due to aequorin consumption 336 during the course of the experiment, resulting in less sensitivity after prolonged exposure to 337 high [Ca 2+ ] (note that luminescence measurements from 6 wells are averaged per time 338 point). When the wild type was treated with 5 µM PAF26, which was above its IC 50 value, the 339 [Ca 2+ ] cyt response followed the same general pattern but with a much larger initial [Ca 2+ ] cyt 340 increase to 0.32 ± 0.02 µM and a shorter period of sustained increase before the [Ca 2+ ] cyt 341 increase became exponential at ~ 430 sec ( Fig. 4B ). Furthermore, after 590 sec following 342 peptide treatment, [Ca 2+ ] cyt spiking was observed. The [Ca 2+ ] cyt response was further 343 accentuated after treatment with a very high dose (10 µM) of PAF26 resulting in a rapid [Ca 2+ ] cyt . This in turn was followed by the [Ca 2+ ] cyt spiking and then a sudden drop in [Ca 2+ ] cyt 346 after ~ 220 sec, which then exponentially increased and subsequently underwent spiking 347 again ( Fig. 4B ). 348
The unstimulated resting level of [Ca 2+ ] cyt in the ∆ yvc-1 mutant was measured as 0.02 349 ± 0.01 µM ( Fig 4A) , significantly different at P >0.01. The [Ca 2+ ] cyt response of the ∆ yvc-1 350 strain to PAF26 was markedly different to that of the wild type. Whilst there was a similar 351 initial immediate, dose dependent increase in [Ca 2+ ] cyt , there was no second exponential 352 increase in [Ca 2+ ] cyt , which was particularly evident after treating the wild type with PAF26 at 353 2.5 µM or above ( Fig. 4B different to the wild type at P > 0.01. Interestingly, deletion of cch-1 does not inhibit the initial 366 increase in [Ca 2+ ] cyt after PAF26 addition, surprising given the lack of evidence for another 367 Ca 2+ channel at the cell surface. The Ca 2+ signatures of the ∆ cch-1 mutant in response to 368 different concentrations of PAF26 were broadly similar to those of the ∆ yvc-1 and ∆ nca-2 369 mutants (Figs. 4B). Thus the ∆ cch-1 mutant also showed an initial [Ca 2+ ] cyt increase but 370 lacked the second [Ca 2+ ] cyt increase of the typical biphasic response of the wild type to 371 PAF26. These results suggest there may be an unidentified L-type channel within the 372 plasma membrane, not CCH-1, being responsible for the initial [Ca 2+ ] cyt increase in response 373 to PAF26. 374
The influence on the [Ca 2+ ] cyt response to 5.0 µM PAF26 of the wild type following 375 pre-treatment with 5 mM BAPTA (to chelate extracellular Ca 2+ ) or with the L-type Ca 2+ 376 channel blockers diltiazem or verapamil (both at 5 mM), was analysed ( Fig. 4C) 
401
In order to investigate whether PAF26 was indeed causing a dose dependent rise in 402 [Ca 2+ ] cyt , conidia expressing GCaMP6s were imaged during PAF26 treatment using widefield 403 fluorescence microscopy. Individual macroconidia were then isolated from the background in 404 FIJI and fluorescence measured over time. As Figure 5A shows, the individual responses 405 are far more varied than the measurements using aequorin suggested. In the middle of the 406 timecourse, the moment the PAF26 reaches the field of view and interacts with the cells can 407 be clearly seen in a sudden increase in Ca 2+ spiking in all the individuals. Given that the 408 aequorin measurements are across a whole population, it is not hard to see how the 409 cumulative effects of an increase in Ca 2+ spikes and waves could be interpreted as a dose 410 dependent rise in [Ca 2+ ] cyt .In order to determine whether there was a predictable response to 411 PAF26 addition, several repeated experiments were run in which the peptide was added and 412 fluorescence intensity recorded. No distinct pattern or regularity was found within any of the 413 data sets, except for an increase in Ca 2+ signalling after PAF26 addition. As the only 414 noticeable response, the amplitude and frequency of these Ca 2+ spikes was quantified. 415
Conidia were treated either with ddH 2 O or ddH 2 O containing 3.5 µM PAF26. A second set 416 were pre-treated with 5 mM BAPTA before ddH 2 O or PAF26 treatment. The conidia treated 417 with ddH 2 O have a relatively low frequency of Ca 2+ spiking with the mean being 4 spikes 418 over the course of the measurement. This is consistent with our findings as to the rate of 419 Ca 2+ spiking in germinating and fusing conidia (Read, unpublished) . When the cells are 420 treated with PAF26 however, there is a marked increase in both frequency and amplitude. 421
The mean frequency of the Ca 2+ spikes increases to 19 and the amplitude increases to 422 around 6 times the resting level from 4 ( Figure 5B ). Both of these results are significant at P 423 < 0.01. When the conidia are pre-treated with BAPTA however, all Ca 2+ spiking ceases 424 completely. Whilst there were no apparent recurring patterns in the spiking events, 425 observations appeared to show that they correspond to vesicles and vacuoles coming into 426 close proximity. A Ca 2+ trace is shown in Fig. 5C and images are shown in Fig. 5D . The 427 images shown in Fig. 5D are taken every five seconds from the timeframes indicated by the 428 black arrows in Fig. 5C . The first Ca 2+ spike marked by *, appears to correspond with the 429 meeting of the two vacuoles at the lower part of the image, whether they fuse or not is 430 unclear. In the images corresponding to the second spike marked with *, the fusion of two In N. crassa, CCH-1 and YVC-1 have not yet been definitively localised while NCA-2 447 has previously been localised to the vacuole and plasma membrane in mature hyphae 448 (Bowman, Draskovic et al. 2009 ). We conducted experiments to localize NCA-2 tagged with 449 obvious signal at the plasma membrane ( Fig. 6 ).). 451
In order to localise the CCH-1 and YVC-1 proteins, plasmids were constructed based 452 on FJ457002 for N-terminal tagging and FJ457006 for C-terminal tagging (Honda and Selker 453 2009). 454
Both the C-and N-terminal YVC-1:GFP fusion proteins fluoresced, although the N-455 tagged protein showed a stronger more stable fluorescence. Fluorescence mainly appeared 456 within vacuoles in conidia, germ tubes and mature hyphae (Fig. 6) . The CCH-1:GFP fusion 457 products produced very little fluorescence, both from N and C tagged versions. This 458 appeared to be localised to vacuoles within conidia and intracellular membranes within older 459 hyphae. Single punctate spots of GFP fluorescence could however be seen at the plasma 460 membrane of mature hyphae, Fig.6 . 461 macroconida re shown for this RFP expressing strain (Bowman, Draskovic et al. 2009 ). CCH-1 466 appears to be localised in the vacuolar system in macroconidia and germlings, but also appears as 467 distinct points in the plasma membrane of mature hyphae. YVC-1 appears to localise to the vacuolar 468 system in all cell types. RFP tagged NCA-2 localises to the vacuole in macroconidia. Bar = 5 μm.
469
DISCUSSION
470
Ca 2+ plays important roles in the mode-of-action of PAF26
471
In this research, evidence for Ca 2+ signaling and homeostasis having a significant 472 role in the PAF26 mode-of-action was obtained initially by testing the PAF26 sensitivity of 473 conidia grown in the presence or absence of calcium. When the level of calcium in the media 474 is kept at a minimal level, tolerance increases. Conversely when the level is raised, tolerance 475 decreases. This was confirmed with deletion mutants defective in different components of 476 their cellular transport machinery of Ca 2+ . Deletion of most of the Ca 2+ channels significantly 477 increased the concentrations at which PAF26 inhibits fungal growth. The elimination of the 478 high affinity Ca 2+ plasma membrane channel CCH-1 and the vacuolar channel YVC-1 as well 479
as the Ca 2+ ATPase resulted in inhibitory concentrations of the peptide approaching the 480 point at which passive membrane permeabilisation occurs. Ca 2+ has been shown to be an 481 important factor in the mechanistics of PMAP-23 against Candida albicans, the disruption 482 results in reactive oxygen species (ROS) accumulation which triggers apoptosis (Kim and 483 Lee 2019). This effect is also seen in the peptide CGA-N9 against C. tropicalis (Li, Chen et 484 al. 2019) . High levels of cytosolic free Ca 2+ have also been shown to confer protection to C. 485 albicans against the antimicrobial MUC7 12mer, thought to be by a resulting change in the 486 cell membrane properties preventing peptide entry (Lis, Liu et al. 2010 ). It appears in this 487 case that the elevated levels of cytosolic free Ca 2+ are a stress response designed to 488 maximise survival by initiating the endocytosis of PAF26. There are significant changes to 489 the pattern of peptide cell interaction in the mutants and to the quantity of peptide the 490 mutants take up. The mutations in the Ca 2+ distribution machinery appear to disrupt the 491 internalisation and accumulation of the peptide which in turn increases tolerance to PAF26. 492
Deletion of nca-2 appears to influence the binding of PAF26 to the cell envelope, the Δ nca-2 493 mutant has been shown to accumulate up to 10 fold more Ca 2+ than wild type cells, 494 suggesting that NCA-2 serves to remove Ca 2+ from the cell (Bowman, Abreu et al. 2011). 495 We found no significant difference in the resting level of [Ca 2+ [ cyt from the wild type however 496 under unstimulated conditions. Interestingly however, the Δ nca-2 mutant has a membrane 497 potential reversed from the wild type due to a lack of cell surface H + ATPase function 498 (Hamam and Lew 2012) . In S. cerevisiae the H + ATPase is one of the most abundant cell 499 surface proteins (Bagnat, Chang et al. 2001 ) and makes up a significant amount (up to 10%) cause a rapid depolarization of the membrane in wild type cells in an energy independent 502 manner (Muñoz, Marcos et al. 2012) . Given that PAF26 has a net positive charge, the 503 membrane potential reversed Δ nca-2 should technically not be inhibited in PAF26 504 membrane binding from an electrostatic view. It is therefore possible to propose that PAF26 505 directly inhibits H + -ATPase action, possibly by direct binding; misfunctioning H + --ATPase at 506 the plasma membrane is sent to the vacuole for degradation in yeast, a possible mechanistic 507 for the accumulation of PAF26 (Bagnat, Chang et al. 2001 , Liu, Sitaraman et al. 2006 . 508
When the peptide is internalised in the Δ yvc-1 mutant, it remains in small vesicles with very 509 little sign of the peptide entering the vacuolar system; adding support for the hypothesis that 510 YVC-1 and a threshold amount of PAF26 is required to initiate vacuolar fusion. Vacuolar 511 fusion occurs through conformational change of the docking SNARE proteins, triggered by 512 the release of Ca 2+ from the vacuole in S. cerevisiae (Bayer, Reese et al. 2003 , Merz and 513 Wickner 2004 , Coonrod, Graham et al. 2013 . In S. cerevisiae, isolated vacuoles are able to 514 catalyse their own fusion through the release of Ca 2+ from yvc1p present in the vacuolar 515 membrane (Peters and Mayer 1998). This does not appear to be the case in N. crassa 516 however, as both deletion of YVC-1 and removal of extracellular Ca 2+ resulted in the trapping 517 of the peptide in small vesicles. Therefore extracellular Ca 2+ is required to initiate the release 518 of Ca 2+ from the vacuoles and trigger fusion. This raises questions as to why internal 519 membrane fusion is reliant on external stimuli. In the Δ cch-1 mutant the peptide was directly 520 translocated across the plasma membrane into the cytoplasm in an energy dependent 521 manner, before accumulation in vacuoles, meaning PAF26 does not kill by being present in 522 the cytosolic space. CCH-1 is therefore required to initiate the endocytic pathway. Energy 523 dependent peptide uptake into the vacuolar system is also seen in the Penicillium 524 chrysogenum Penicillium antifungal protein B (PAFB), where the fungal cells show no signs 525 of cell death as long as the peptide remains in the vacuole (Huber, Hajdu et al. 2018) . This is 526 similarly seen in the Neosartorya (Aspergillus) fischeri antifungal protein (NFAP), which is 527 also accumulated in the vacuole in an energy dependent maner. Again, this peptide also 528 does not exert its antifungal effects until it is present within the cytoplasm (Hajdu, Huber et 529 al. 2019 ). This contrasts the findings here of PAF26 being present within the cytoplasmic 530 space without killing the cells. The importance of the vacuole in the mode of action of many 531 antifungal peptides is becoming increasingly apparent. A genetic screen of S. cerevisiae 532 revealed tolerance to the plant antifungal defensins NbD6 and SBI6 could be increased by 533 deletion of genes involved in vacuolar transport (Parisi, Doyle et al. 2019) .
initial increase was independent of CCH-1, as the signal in the Δ cch-1 mutant increased, but 538 was dependent on external Ca 2+ and L-type Ca 2+ channels. The fact that L-type channel 539 blockers completely stop the [Ca 2+ ] cyt increase as does the chelation of external Ca 2+ using 540 BAPTA would suggest that there is another, as yet unknown cell surface Ca 2+ channel. 541
These findings mirror those of Binder et al., 2010, who found that deletion of cch-1 did not 542 prevent the increase in [Ca 2+ ] cyt in response to P. chrysogenum Penicillium antifungal protein 543 (PAF). When these measurements were taken at the level of the individual, rather than the 544 population, it became apparent that PAF26 does not in fact cause a dose dependent rise in 545 [Ca 2+ ] cyt but rather increases both the amplitude and frequency of Ca 2+ spiking, again 546 dependent on the presence of external Ca 2+ . These findings have allowed us to propose the 547 model shown in Fig. 7 for the role of Ca 2+ signalling and homeostasis in the mode of action 548 of PAF26. Now the challenge is to identify the trigger of vacuolar release of PAF26 and the 549 initiator of cell death. 550 
559
OR23-1VA) was used as the wild type control. N. crassa strains generated in this study were 564 derived from FGSC9717 (matA,∆mus-51::bar + ; his-3 -), FGSC9720 (matA,∆mus-52::bar + ; his-565 3 -) and FGSC6103 (matA,his-3 -) N. crassa was cultured and maintained according to FGSC 566 protocols (www.fgsc.net/Neurospora/NeurosporaProtocolGuide.htm) unless otherwise 567 stated. 568 AscI and NotI. Following gel extraction both vectors were assembled using Gibson 587 assembly. 588
Tagging of CCH-1 was not straightforward due to the size of the ORF -6.5kb. The 589 CCH-1 ORF was amplified first using the primer sets NC-CCH1 AMP-FW and NC-CCH1-590 3.5Rv and NC-CCH1-3.5Fw and NC-CCH1-AMP-RV to amplify the gene in two segments, 5' 591 and 3'. The complete constructs were built using fusion PCR; primer NC-CCH1-C-FW, 5' 592 segment, 3' segment and primer NC-CCH1-C-RV, the N terminal tagging vector used the 593 primers NC-CCH1-N-FW and NC-CCH1-N-RV. Following successful fusion the vectors were concentration was of 5 X 10 5 in 10% VM. Absorbance measurements were obtained at 610 603 nm. This wavelength is close to the 595nm at which the relationship between optical density 604 and fungal biomass is linear (Broekaert, Terras et al. 1990) . 605 All microscopy was carried out on a Nikon Eclipse ® TE2000-E inverted microscope, 639 using a Nikon Plan Apo 60 X 1.2 N.A. DIC H water immersion objective and Nikon G-2A and 640 B-2A filter sets, excitation was provided by a CoolLED illumination system set at 550 nm for 641 use with the G-2A filter or 470 nm for use with the B2-A filter. 642
Calcium measurements
Confocal microscopy was carried out using a Leica TCS SP8 equipped with two 643 hybrid GaAsP detectors (HyD) and two photomultiplier tubes (PMT). Excitation was provided 644 using either the Leica tuneable white light laser (450 -750 nm), an argon laser (458nm, 645 476nm, 488nm and 496nm) or UV laser (405nm). Images were captured using LAS X 646 software and the Leica 63 X water immersion objective. All image handling and analysis was 647 carried out using Fiji (fiji.sc/Fiji). 648
Quantification of Ca 2+ signalling
649 Fluorescence values were exported from Fiji and analysed in Excel. Data was 650 normalised using feature scaling. This scales the data to removes irregularities in GCaMP6 651 expression and photon yield. The function used was: x I = MIN + (x-min x )(MAX-MIN)/(max x -normalised value. min x is the minimum value for that data set and max x is the maximum, 654 max x was defined as the maximum value from all experiments plus 10 to avoid artificial 655 amplification of noise. The noise was removed using an IF function: =IF(x>y,x,0) where x is 656 the data point and y is the noise threshold limit. Finally, an IF(AND(x>x -1 , x>x +1 ),1,0) 657 function, where x -1 and x +1 are the surrounding measurements, quantified each peak in 658 
